Skip to Main Content

Paper Details

Newly marketed medications present unique challenges for nonrandomized comparative effectiveness analyses.
J Comp Eff Res
10
2012
Author NameAffiliation
Jeremy A RassenDivision of Pharmacoepidemiology & Pharmacoeconomics, Brigham & Women's Hospital & Harvard Medical School
  • 1 - 1

Datasets

Release 1.2